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Review of a terminology proposed 
to supersede Miltenberger 
M.E. REID AND P. TIPPETT 
The term Miltenberger has been used since 1966 to 
describe phenotypes for a subsystem of MNS-related 
blood group antigens. Initially, Miltenberger was used 
to describe red blood cells (RBCs) with one of four 
phenotypes that were agglutinated by the serum of 
Mrs. Miltenberger. l Mi.V was added because although 
these RBCs are not agglutinated by the Miltenberger 
serum, they expressed the Hil antigen (which is also 
expressed by Mi.III RBCS).2 To date, there are ten anti- 
gens associated with the Miltenberger subsystem, and 
the number of classes has now expanded to 11 (Table 
1). References for subclasses Mi.I to Mi.IX can be 
found in recent review.3-5 Subclass Mi.X(HF) was 
reported recently6 and, based on reactivity with anti- 
TSEN7 and anti-MINY,8 it has been suggested that JL 
be regarded as Mi.XI.4 Only some of these RBCs are 
agglutinated by Mrs. Miltenberger's serum, and the 
Mia antigen (MNS7) is not included in Table 1 because 
no separable anti-Mia is available.5 The Miltenberger 
phenotypes have been numbered chronologically, 
and it is becoming increasingly difficult to remember 
which antigens are associated with each phenotype. 
In addition, since anti-DANE agglutinates Mg-positive 
RBCs9 such cells would become a new Miltenberger 
Table 1. Existing Miltenberger classes and associated antigens 
class and anti-Mg a further Mi-related antibody; Tippett 
et al.5 suggested that the Miltenberger terminology 
has outlived its usefulness and that, unless it is abol- 
ished, it is inevitable that other phenotypes will be 
added to the subsystem. Now that the biochemical 
and molecular basis of these phenotypes has been 
established, a terminology based on these findings 
might be more useful, practical, and descriptive. The 
terminology recommended by Tippett et al.5 and 
detailed here not only is practical and descriptive, but 
also can be used for other glycophorin (GP) 
molecules, as described in this review. 
Abolition of Miltenberger Subsystem and 
Replacement Terminology 
All antigens in the Miltenberger subsystem are car- 
ried on glycophorin A (GPA), glycophorin B (GPB), or 
hybrid molecules composed of different proportions 
of GPA and GPB. For this reason, they belong in the 
MNS system and there appears to be no further value 
in separating them into a subsystem. 
The phenotype is represented by the abbreviation 
GP (for glycophorin), followed by a period and an 
abbreviation of the name of the first propositus or 
Antigens 
Vw Hut Mur MUT Hil TSEN MlNY Hop Nob DANE 
MNSs:* 9 19 10 35 20 33 34 26 27 32 
Mi.I + 0 0 0 0 0 0 0 0 0 
Mi.II 0 + 0 + 0 0 0 0 0 0 
Mi.III 0 0 + + + 0 + 0 0 0 
Mi.IV 0 0 + + 0 + + + 0 0 
Mi.V 0 0 0 0 + 0 + 0 0 0 
Mi.VI 0 0 + + + 0 + + 0 0 
Mi.VIl 0 0 0 0 0 0 0 0 + 0 
Mi.VIlI 0 0 0 0 0 NT 0 + + 0 
Mix 0 0 + 0 0 0 0 0 0 + 
Mi.X 0 0 0 + + 0 + 0 0 0 
Mi.XI 0 0 0 NT† 0 + + 0 0 0 
*MNS blood group system number assigned by the ISBT Working Party for the Terminology of Red Cell Surface Antigens10 
†Not tested 
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familiar name (Table 2). In most cases, the initial or 
abbreviation represents one of the significant antigens 
and is therefore more user-friendly than a subsystem 
number. A period after GP is used to distinguish the 
phenotype from the notation for the glycophorin vari- 
ant. The antigen profiles for GP.Vw and GP.Hut phe- 
notypes can be defined simply as Vw+ and Hut+, 
respectively, since these antigens are unique to these 
phenotypes. However, since the specific antigens 
associated with the other phenotypes are shared by 
more than one Miltenberger class, our suggestion is 
to document the minimum number of antigens need- 
ed to distinguish the phenotypes. The antigens can be 
Table 2. Suggested terminology for Miltenherger phenotypes 
recorded as symbols or as International Society of 
Blood Transfusion (ISBT) numbers. 10 Documentation 
of the absence of some antigens as well as the pres- 
ence of other antigens is required to distinguish some 
phenotypes. The suggested serological phenotypes 
shown in Table 2 are those most easily determined in 
the authors' laboratories. Other phenotypes might be 
used if other antibodies were readily available. For 
example, GP.Dane could be precisely defined as 
DANE+ Mg- if anti-DANE were available. 
Using this terminology, it is easy to cluster the phe- 
notypes, based on their constituent GP hybrid 
molecules (Table 3 ) .  GP(A-B) and GP(B-A) hybrid 
Shorthand symbol Serological phenotype 
First 
propositus Current Proposed Symbolic Numeric 
Vw Mi.I GP.VW Vw+ 
Hut Mi.ll GP.Hut Hut+ 
Mur Mi.III GP.Mur Mur+Hi l+Hop 
HOP Mi.IV Gp.Hop Mur+Hil-Hop+ 
Rog Mi.V GP.Hil* Mur-Hil+MUT- 
Bun Mi.Vl GP.Bun Mur+Hil+Hop+ 
Nob Mi.VII GP.Nob Hop-Nob+ 
Joh Mi.VIII GP.Joh Hop+Nob+ 
Dane Mi.IX GP.Dane Mur+DANE+MUT- 
HF Mi.X GP.HF Mur-Hil+MUT+ 
JR Mi.XI GP.JL† Mur-TSEN+ 
*The familiar name instead of the name of the first propositus is used for the Mi.V phenotype. 












Table 3. Phenotypes arranged according to their constituent glycophorins 




































Mur, MUT, Hil, MINY 
Mur, MUT, Hop, Hil, MINY 
MUT, Hil, MlNY 
Mur, MUT, Hop, TSEN, MlNY 
ERIK, Sta 
substitution‡ 
*Previously thought t o  he the consequence of a nucleotide substitution, hut  now considered more likely to be due to gene conversion resulting in 
†Deduced fmm antigen typings. 
$Gene results in more than 1 transcript. 
GP(A-B-A) hybrid molecules.15 GP.Vw and GP.Hut could also. theoretically. arise from a single nucleotide substitution in the GYPA gene. 
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molecules arise from a single homologous crossover 
between GYPA and GYPB genes on misaligned chro- 
mosomes. At the protein level (but not necessarily at 
the DNA level), GP.Hil and GP.JL are reciprocal prod- 
ucts to GP.Scb3 (previously the Mr type of St[a+]), 
while GP.TK is the reciprocal product to GP.Dantu (C- 
H Huang and OO Blumenfeld, personal communica- 
tion). No  novel blood group antigens have been 
associated with GP.MEP, and the expected reciprocal 
GP(B-A) hybrid molecule has not been found. 
GP(A-B-A) and GP(B-A-B) hybrid molecules most 
probably arise through gene conversion.3 
Further Details of Some Phenotypes 
When the biochemical structure of the variant gly- 
cophorin has been determined, this information 
could be used in conjunction with the identifying 
symbols of the first propositus. For example, the 
GP.Bun phenotype, which is associated with a 
GP(B-A-B) hybrid molecule, can be represented as 
GP(B-A-B)Bun or, if the Ss status is important, as 
GP. (B-A-Bs)Bun. A more extended phenotype 
description is unlikely to be useful but, if the gly- 
cophorin or its gene has been sequenced, the contri- 
butions of each parent glycophorin can be indicated 
to describe the glycophorin molecule, e.g., 
GP(B-A-BThr29) (A58, B27)Bun; GP(B-yB-A-BThr29) 
(A58,B27)Bun; or, if the pseudo GPB to GPA junction 
is known, GP(B-yB-A-B)(B28,A56;A59,B27). Thr29 
(or Metz29) written as a superscript denotes amino acid 
29 of the parent glycophorin B, which would nor- 
mally express s (or S) antigen. Information in the sec- 
ond set of parentheses represents amino acid 
involved in junctions (determined or deduced) 
between the two glycophorins; the junction is denot- 
ed by a comma. If detail is not required, this gly- 
cophorin could be referred to as GP.Bun or 
GP(B-A-B)Bun. The terminology described above 
uses numbers for amino acid residues associated with 
the parent glycophorin molecules. Each variant gly- 
cophorin molecule can also be represented by the 
amino acid residues within it (Table 4). 
Different genetic events can generate the same 
amino acid sequence and therefore give rise to the 
Table 4. Phenotypes arranged according to  their constituent glycophorin hybrid molecules and terminology to  denote glycophorin alteration 
Molecular Phenotype Associated novel 
basis Glycophorin symbol antigens Glycophorin alterations$ Variant glycophorins§ 
GYP(A-B) GP(A-B) GP.MEP(En[a-]UK) 
GP.Hil(Mi.V) 
GP.TK 
GYP(B-A) GP(B-A) GP.Sch(Mr) 
GP.Dantu 

























Mur, MUT, Hil, MlNY 
Mur, MUT, Hop, Hil, MlNY 
MUT, Hil, MINY 















substitution* GP(A-A) sta GP(A-A) (A26,A59) 
Note: If GP.Nob, GP.Joh, GP.Vw, and GP.Hut also arise from nucleotide substitutions, they would be written as follows: 
GP.Nob GPA(49->Tbr ;52Thr ->Ser )  GPAThr49,Ser52Nob 
GP.Vw GPA(28Thr->Met) GPAMet28Vw 
GP.Joh GPA(49Arg->Thr) GPATk49Joh 
GP.Hut GPA(28Thr->Lys) GPALys28Hut 
*Genes that result in  more than 1 transcript.11,12 
†Deduced from antigen typings. 
‡Numbers refer to  amino acids derived from the parent glycophorin molecules 
§Superscript numbers represent residue number in variant glycophorin. 
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same blood group antigen. Thus, different glycophorin 
molecules have been shown to carry the same novel 
antigen. For example, the Hil antigen is found on the 
GP(B-A-B) hybrid molecules associated with GP.Mur 
(Mi.III), GP.Bun (Mi.VI), and GP.HF (Mi.X), as well as 
on the GP(A-B) hybrid molecules that bear its name, 
GP.Hil (Mi.V). In each case, the amino acid sequence 
that gives rise to the novel antigen is identical. 
A Single Genomic DNA Sequence That Can 
Encode More Than One mRNA Transcript 
Some genetic events lead to genes that generate 
more than one mRNA transcript from a single 
sequence of DNA; in such cases, the glycophorin 
product of one transcript can carry one antigen, and 
the glycophorin product of a second transcript can 
carry a different antigen. For example, the nucleotide 
substitution with the GYPA gene found in GP.EBH 
people results in two distinct glycophorin molecules 
in the red cell membrane: transcript 1 (tl) encodes a 
GPA with one amino acid substitution that is respon- 
sible for the low-incidence antigen ERIK,12,13 while 
transcript 2 (t2) encodes a shortened form of GPA that 
carries the Sta antigen. The same gene is responsible 
for two other transcripts, but the third transcript (t3) 
and a fourth transcript (t4) do  not encode a mem- 
brane-bound protein.12 The novel antigen character- 
istic of the protein encoded by a particular transcript 
can be designated by the ISBT blood group antigen 
number after the period following the transcript num- 
ber (Table 4). For example, Sta antigen is expressed by 
GP(A1-26-A27-99) Zan.t1.15 in GP.Zan (previously 
called Mz) and by GP(A1-26-A27-94) EBH.t2.15 in the 
recently reported GP.ERIK phenotype (Table 4). 
Glycophorins From Different Species 
when referring to 
glycophorins from different species, the initial of that 
species can precede the glycophorin abbreviation. 
Thus, HGP is used for human glycophorin, CGP for 
chimpanzee, and OGP for orangutan, etc. 
Identical Hybrid Glycophorins Arising From 
Different Intronic Crossover Sites 
Huang and colleagues14 have reported that GP.Sch 
(Mr) can arise from recombination events at more 
than one site in intron 3. These investigators have 
named the three known ones: type A, type B, and type 
C. N o  doubt there will be others, and when they are 
As suggested by Huang et 
found we recommend that this terminology prece. 
dent be followed. 
Conclusion 
It is apparent that this proposed new terminology 
abolishes the concept of a subsystem. However, since 
all antigens in the Miltenberger subsystem are carried 
on altered forms of glycophorin A and glycophorin B, 
they clearly belong in the MNS blood group system 
and, in fact, all possess ISBT numbers within the MNS 
blood group system. Furthermore, information from 
biochemical and molecular biological studies provides 
explanations for most of the serologic relationships. 
The proposed terminology is flexible and can be 
applied to describe other phenotypes. It may be par- 
ticularly helpful in cases in which one antigen arises 
from more than one genetic event. For example, 
GP.Sch, which carries the Sta antigen, is a GP(B-A) 
hybrid molecule whose alteration can be denoted as 
GP(B-A)(B26, A59)Sch. A second mechanism that 
gives rise to a glycophorin molecule carrying the Sta 
antigen is associated with a nucleotide substitution in 
the GYPA gene.12 This type, GP.EBH, has been men- 
tioned above. The third mechanism is one of gene 
conversion, as seen in GP.Zan.11 The GP.Zan molecule 
is encoded by a W(A-pseudo B-A) gene that gives 
rise to a shorter form of glycophorin A:GPA(A26,A59) 
Zan that carries the Sta antigen. 
The proposed terminology relates to the altered 
gene, the variant glycophorin, and the novel antigens 
associated with it. As with the Miltenberger terminol- 
ogy for phenotypes, the new terminology does not 
address the contribution of blood group antigens 
encoded by normal glycophorin genes on the same 
partner chromosomes. 
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